首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Variations in Amino Acid Composition of Antisense Peptide-Phosphorodiamidate Morpholino Oligomer Affect Potency against Escherichia coli In Vitro and In Vivo
【2h】

Variations in Amino Acid Composition of Antisense Peptide-Phosphorodiamidate Morpholino Oligomer Affect Potency against Escherichia coli In Vitro and In Vivo

机译:反义肽-磷酸二氨基磷酸盐吗啉代寡聚物氨基酸组成的变化对大肠杆菌的体内和体外影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The potency of antisense peptide-phosphorodiamidate morpholino oligomers (PPMOs) was improved by varying the peptide composition. An antisense phosphorodiamidate morpholino oligomer (PMO) complementary to the mRNA of the essential gene acpP (which encodes the acyl carrier protein required for lipid biosynthesis) in Escherichia coli was conjugated to the 5′ ends of various cationic membrane-penetrating peptides. Each peptide had one of three repeating sequence motifs: C-N-N (motif 1), C-N (motif 2), or C-N-C (motif 3), where C is a cationic residue and N is a nonpolar residue. Variations in the cationic residues included arginine, lysine, and ornithine (O). Variations in the nonpolar residues included phenylalanine, valine, β-alanine (B), and 6-aminohexanoic acid (X). The MICs of the PPMOs varied from 0.625 to >80 μM (about 3 to 480 μg/ml). Three of the most potent were the (RX)6B-, (RXR)4XB-, and (RFR)4XB-AcpP PMOs, which were further tested in mice infected with E. coli. The (RXR)4XB-AcpP PMO was the most potent of the three conjugates tested in mice. The administration of 30 μg (1.5 mg/kg of body weight) (RXR)4XB-AcpP PMO at 15 min postinfection reduced CFU/ml in blood by 102 to 103 within 2 to 12 h compared to the numbers in water-treated controls. All mice treated with 30 μg/dose of (RXR)4XB-AcpP PMO survived infection, whereas all water-treated mice died 12 h postinfection. The reduction in CFU/ml in blood was proportional to the dose of PPMO from 30 to 300 μg/ml. In summary, the C-N-C motif was more effective than the other two motifs, arginine was more effective than lysine or ornithine, phenylalanine was more effective than 6-aminohexanoic acid in vitro but not necessarily in vivo, and (RXR)4XB-AcpP PMO reduced bacterial infection and promoted survival at clinically relevant doses.
机译:通过改变肽组成,反义肽-磷酸二氨基酯吗啉代低聚物(PPMO)的效能得以提高。与在大肠杆菌中的必需基因acpP(编码脂质生物合成所需的酰基载体蛋白)的mRNA互补的反义二氨基磷酸吗啉代寡聚物(PMO)与各种阳离子膜穿透肽的5'末端缀合。每个肽具有以下三个重复序列基序之一:C-N-N(基序1),C-N(基序2)或C-N-C(基序3),其中C为阳离子残基,N为非极性残基。阳离子残基的变化包括精氨酸,赖氨酸和鸟氨酸(O)。非极性残基的变化包括苯丙氨酸,缬氨酸,β-丙氨酸(B)和6-氨基己酸(X)。 PPMO的MIC从0.625到> 80μM(约3至480μg/ ml)变化。最有效的三种是(RX)6B-,(RXR)4XB-和(RFR)4XB-AcpP PMO,它们已在感染了大肠杆菌的小鼠中进行了进一步测试。 (RXR)4XB-AcpP PMO是在小鼠中测试的三种结合物中最有效的。感染后15分钟施用30μg(1.5 mg / kg体重)(RXR)4XB-AcpP PMO,血液中的CFU / ml降低10 2 至10 3 在2到12小时内与水处理对照中的数字相比。用30μg/剂量的(RXR)4XB-AcpP PMO处理的所有小鼠均幸免于感染,而所有用水处理的小鼠在感染后12 h死亡。血液中CFU / ml的降低与PPMO剂量从30到300μg/ ml成正比。总之,在体外,但不一定在体内,CNC主题比其他两个主题更有效,精氨酸比赖氨酸或鸟氨酸更有效,苯丙氨酸比6-氨基己酸更有效,并且(RXR)4XB-AcpP PMO降低细菌感染并以临床相关剂量促进生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号